Guangxi LiuYao Group(603368) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Liuyao Group: Summary of the 2024 Annual Report of Guangxi Liuyao Group Co., Ltd.
SZSI12:00 ET · Announcements
Liuyao Group: Guangxi Liuyao Group Co., Ltd. 2024 Annual Report
SZSI12:00 ET · Announcements
Guangxi Liuyao Group Co., Ltd. 2024 Annual Report
SZSI12:00 ET · Announcements
Summary of the 2024 Annual Report of Guangxi Liuyao Group Co., Ltd.
SZSI12:00 ET · Announcements
Guangxi LiuYao Group (603368.SH): In 2024, the net income is 0.855 billion yuan, with a year-on-year increase of 0.62%. It plans to distribute 7.51 yuan per share.
Gelonghui, on March 26, announced that Guangxi LiuYao Group (603368.SH) released its annual report for 2024, achieving revenue of 21.182 billion yuan during the reporting period, a year-on-year increase of 1.78%; net income attributable to shareholders of the listed company was 0.855 billion yuan, a year-on-year increase of 0.62%; basic EPS was 2.21 yuan. It is proposed to distribute a cash dividend of 7.51 yuan (including tax) for every 10 shares to all shareholders.
Gelonghui FinanceMar 26 04:46 ET
Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Prospects Need A Boost To Lift Shares
Simply Wall StMar 13 22:33 ET

Comments

Moomoo AI

Feb 24, 2024 10:30

The low P/E ratio of Guangxi LiuYao Group is attributed to the market's expectation of limited future growth. Unless the company's earnings outlook improves, the share price is likely to remain at the current levels.

Investors Aren't Buying Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Earnings

Gator on Wall Street

Aug 30, 2022 17:23

DBS: China Healthcare Sector – Pharmaceutical Packaging

https://alphaedgeinvesting.com/2022/08/30/dbs-china-healthcare-sector-pharmaceutical-packaging/
$MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $CSPC PHARMA (01093.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

Gator on Wall Street

Jul 1, 2022 18:58

DBS: China Biotech Sector

https://alphaedgeinvesting.com/2022/07/01/dbs-china-biotech-sector/
$BEIGENE (06160.HK)$ $CSPC PHARMA (01093.HK)$ $HENLIUS (02696.HK)$ $MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

603368 Guangxi LiuYao Group

Trade Overview

Capital Trend

News

Comments

Market Insights